Jones RJ - Search Results

1

Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors.

Angstreich GR, Matsui W, Huff CA, Vala MS, Barber J, Hawkins AL, Griffin CA, Smith BD, Jones RJ. Angstreich GR, et al. Among authors: jones rj. Br J Haematol. 2005 Aug;130(3):373-81. doi: 10.1111/j.1365-2141.2005.05606.x. Br J Haematol. 2005. PMID: 16042686 Free article.

2

Fluorescence in situ hybridization to determine engraftment status after murine bone marrow transplant.

Hawkins AL, Jones RJ, Zehnbauer BA, Zicha MS, Collector MJ, Sharkis SJ, Griffin CA. Hawkins AL, et al. Among authors: jones rj. Cancer Genet Cytogenet. 1992 Dec;64(2):145-8. doi: 10.1016/0165-4608(92)90345-9. Cancer Genet Cytogenet. 1992. PMID: 1486564

3

Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitors.

Rowinsky EK, Donehower RC, Spivak JL, Burke PJ, Griffin CA, Jones RJ. Rowinsky EK, et al. Among authors: jones rj. J Natl Cancer Inst. 1990 Dec 19;82(24):1926-31. doi: 10.1093/jnci/82.24.1926. J Natl Cancer Inst. 1990. PMID: 2250314

4

BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents.

Bedi A, Barber JP, Bedi GC, el-Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J, Jones RJ. Bedi A, et al. Among authors: jones rj. Blood. 1995 Aug 1;86(3):1148-58. Blood. 1995. PMID: 7620167 Free article.

5

Inhibition of apoptosis during development of colorectal cancer.

Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ. Bedi A, et al. Among authors: jones rj. Cancer Res. 1995 May 1;55(9):1811-6. Cancer Res. 1995. PMID: 7728743

6

Assessment of aldehyde dehydrogenase in viable cells.

Jones RJ, Barber JP, Vala MS, Collector MI, Kaufmann SH, Ludeman SM, Colvin OM, Hilton J. Jones RJ, et al. Blood. 1995 May 15;85(10):2742-6. Blood. 1995. PMID: 7742535 Free article.

7

Growth factor-mediated terminal differentiation of chronic myeloid leukemia.

Bedi A, Griffin CA, Barber JP, Vala MS, Hawkins AL, Sharkis SJ, Zehnbauer BA, Jones RJ. Bedi A, et al. Among authors: jones rj. Cancer Res. 1994 Nov 1;54(21):5535-8. Cancer Res. 1994. PMID: 7923192

8

Biology of chronic myeloid leukemia and its relevance to autologous bone marrow transplantation.

Jones RJ, Bedi A. Jones RJ, et al. Curr Opin Oncol. 1994 Mar;6(2):122-6. doi: 10.1097/00001622-199403000-00002. Curr Opin Oncol. 1994. PMID: 8011689 Review.

9

Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia.

Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ. Bedi A, et al. Among authors: jones rj. Blood. 1994 Apr 15;83(8):2038-44. Blood. 1994. PMID: 8161775 Free article.

10

BMT for severe aplastic anemia using cyclosporine.

May WS, Sensenbrenner LL, Burns WH, Ambinder R, Carroll MP, Griffin CA, Jones RJ, Miller CB, Mellits ED, Vogelsang GB, et al. May WS, et al. Among authors: jones rj. Bone Marrow Transplant. 1993 Jun;11(6):459-64. Bone Marrow Transplant. 1993. PMID: 8334426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters